Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

By Jack Cuzick, F. Otto, J. Baron, P. Brown, J. Burn, P. Greenwald, J. Jankowski, C. la Vecchia, F. Meyskens, H. Senn and 1 more. The Lancet Oncology, 2009

707 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pharmacology, Surgery

View Paper: https://www.semanticscholar.org/paper/758e6b223f0de0fa8bfb6027fe35ca8b4ae6a9be

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pharmacology

1. Dingzhi Wang
2. R. Dubois

Citations in the corpus

• Eicosanoids and cancer (2010, background): “Long-term use of high doses of selective COX2 inhibitors is currently not recommended because of the unacceptable cardiovascular side effects in certain patients, especially those with a history of atherosclerotic heart diseas”
• Cancer-related inflammation: common themes and therapeutic opportunities. (2012, neutral): “[89].”
• Meta-analyses of Colorectal Cancer Risk Factors (2013, background): “As we have concluded that the restricted cubic spline fit is a good fit, there is no evidence of heterogeneity (i.e., there is no significant difference between NSAIDs and aspirin), yet there is a trend of some effect.”